Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Biomaterials Science

Background:

• Adipose tissue is a rich, accessible source of mesenchymal stem cells for bone tissue engineering.
• The heterogeneous stromal vascular fraction (SVF) from adipose tissue yields unreliable bone formation.
• Purified perivascular stem cells (PSCs) from adipose tissue offer a more consistent cell source.

Purpose of the Study:

• To compare the bone-forming capacity of purified human PSCs against traditional SVF.
• To optimize PSCs for in vivo bone formation using biomaterials.
• To evaluate the efficacy of novel osteoinductive factors for PSC-mediated bone regeneration.

Main Methods:

• Prospective purification of human PSCs (pericytes and adventitial cells) via fluorescence-activated cell sorting.
• In vitro osteogenic differentiation and in vivo intramuscular implantation of PSCs.
• Optimization using demineralized bone matrix and tricalcium phosphate; evaluation of recombinant bone morphogenetic protein 2 and NELL-1.

Main Results:

• PSCs demonstrated robust osteogenic differentiation in vitro and bone formation in vivo without predifferentiation.
• Patient-matched PSCs generated significantly more bone than SVF across all measured parameters.
• Recombinant NELL-1 selectively enhanced PSC osteogenesis, while bone morphogenetic protein 2 induced significant adipogenesis.

Conclusions:

• Adipose-derived human PSCs represent a novel, highly effective cell source for skeletal regenerative medicine.
• PSCs offer a potentially safer, purer, and more potent stem cell therapeutic for FDA approval.
• NELL-1 is a promising growth factor for inducing PSC osteogenesis and enhancing bone formation.